• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性精神分裂症患者的长效癸酸氟奋乃静维持剂量需求

Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients.

作者信息

Capstick N

出版信息

Acta Psychiatr Scand. 1980 Mar;61(3):256-62. doi: 10.1111/j.1600-0447.1980.tb00875.x.

DOI:10.1111/j.1600-0447.1980.tb00875.x
PMID:7376929
Abstract

Forty-seven schizophrenic out-patients, who were satisfactorily maintained on a depot injection of fluphenazine decanoate, and who received the injection every 28 days, were progressively withdrawn from medication by increasing the time interval between injections while maintaining the amount of of drug per injection. The rate of reduction varied with each patient depending on various factors such as environmental stress considerations, and the patient's wishes. Finally three injections at 8-weekly intervals were given before complete withdrawal. The follow-up period was 23.7 months with a standard deviation of 1.9. A relapse rate of 80% was found, 25 patients relapsing during the withdrawal phase and 22 patients after the drug had been completely withdrawn.

摘要

47名精神分裂症门诊患者,他们通过癸酸氟奋乃静长效注射剂得到了满意的维持治疗,且每28天接受一次注射,在保持每次注射药物量不变的情况下,通过增加注射间隔时间逐步停药。减药速度因患者而异,取决于各种因素,如环境压力因素和患者意愿。最后,在完全停药前每8周注射一次,共注射三次。随访期为23.7个月,标准差为1.9。发现复发率为80%,25名患者在减药阶段复发,22名患者在药物完全停用后复发。

相似文献

1
Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients.慢性精神分裂症患者的长效癸酸氟奋乃静维持剂量需求
Acta Psychiatr Scand. 1980 Mar;61(3):256-62. doi: 10.1111/j.1600-0447.1980.tb00875.x.
2
A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.长效抗精神病药物撤药研究。一项关于慢性精神分裂症患者停用长效氟奋乃静癸酸酯和长效三氟噻吨癸酸酯临床效果的对照研究。
Acta Psychiatr Scand. 1981 Jul;64(1):65-84. doi: 10.1111/j.1600-0447.1981.tb00761.x.
3
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.癸酸氟哌啶醇与癸酸氟奋乃静在预防复发的六个月治疗期间的有效性、副作用、剂量及血清水平的双盲比较
Pharmacopsychiatry. 1985 May;18(3):240-5. doi: 10.1055/s-2007-1017373.
4
Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
Neuropsychobiology. 1978;4(6):360-5. doi: 10.1159/000117652.
5
Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.癸酸氟哌啶醇替代癸酸氟奋乃静进行精神分裂症及其他慢性精神病的维持治疗。
Acta Psychiatr Belg. 1982 Mar-Apr;82(2):216-23.
6
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.癸酸氟哌啶醇与癸酸氟奋乃静作为慢性精神分裂症住院患者维持治疗的比较
Br J Psychiatry. 1987 Sep;151:333-6. doi: 10.1192/bjp.151.3.333.
7
Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.双盲安慰剂替代:精神分裂症患者中癸酸氟奋乃静的撤药研究
J Clin Psychiatry. 1982 May;43(5):195-6.
8
Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.采用放射免疫分析法测定接受氟奋乃静癸酸酯长效注射治疗的精神分裂症患者的血浆氟奋乃静水平。
Br J Clin Pharmacol. 1979 Dec;8(6):565-70. doi: 10.1111/j.1365-2125.1979.tb01045.x.
9
Persistence of fluphenazine in plasma after decanoate withdrawal.癸酸酯停药后氟奋乃静在血浆中的持续存在。
J Clin Psychopharmacol. 1988 Feb;8(1):53-6.
10
A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.五氟利多与癸酸氟奋乃静治疗门诊精神分裂症患者的长期对照试验。
J Clin Psychiatry. 1978 Apr;39(4):375-9.

引用本文的文献

1
A review of patient outcomes in pharmacological studies from the psychiatric literature, 1966-1993.
Sci Eng Ethics. 1997 Oct;3(4):395-406. doi: 10.1007/s11948-997-0043-1.
2
Depot antipsychotic drugs. Place in therapy.长效抗精神病药物。在治疗中的应用。
Drugs. 1994 May;47(5):741-73. doi: 10.2165/00003495-199447050-00004.
3
Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.精神分裂症患者的药物治疗。过去和现在的问题以及未来潜在的治疗方法。
Drugs. 1990 Apr;39(4):481-8. doi: 10.2165/00003495-199039040-00001.